{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:56:23Z","timestamp":1792220183245,"version":"4.4.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T00:00:00Z","timestamp":1407196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s12020-014-0357-0","type":"journal-article","created":{"date-parts":[[2014,8,4]],"date-time":"2014-08-04T07:23:08Z","timestamp":1407136988000},"page":"65-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Osteoporosis in patients taking selective serotonin reuptake inhibitors: a focus on fracture outcome"],"prefix":"10.1007","volume":"48","author":[{"given":"Olivier","family":"Bruy\u00e8re","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Reginster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,8,5]]},"reference":[{"issue":"1","key":"357_CR1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1017\/S1121189X00001974","volume":"15","author":"ES Paykel","year":"2006","unstructured":"E.S. Paykel, Depression: major problem for public health. Epidemiol. Psichiatr. Soc. 15(1), 4\u201310 (2006)","journal-title":"Epidemiol. Psichiatr. Soc."},{"issue":"1","key":"357_CR2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3122\/jabfm.2011.01.100121","volume":"24","author":"RS Shim","year":"2011","unstructured":"R.S. Shim, P. Baltrus, J. Ye, G. Rust, Prevalence, treatment, and control of depressive symptoms in the United States: results from the National Health and Nutrition Examination Survey (NHANES), 2005\u20132008. J. Am. Board Fam. Med. 24(1), 33\u201338 (2011). doi: 10.3122\/jabfm.2011.01.100121","journal-title":"J. Am. Board Fam. Med."},{"issue":"s420","key":"357_CR3","first-page":"21","volume":"190","author":"J Alonso","year":"2004","unstructured":"J. Alonso, M.C. Angermeyer, S. Bernert, R. Bruffaerts, T.S. Brugha, H. Bryson, G. de Girolamo, R. Graaf, K. Demyttenaere, I. Gasquet, J.M. Haro, S.J. Katz, R.C. Kessler, V. Kovess, J.P. Lepine, J. Ormel, G. Polidori, L.J. Russo, G. Vilagut, J. Almansa, S. Arbabzadeh-Bouchez, J. Autonell, M. Bernal, M.A. Buist-Bouwman, M. Codony, A. Domingo-Salvany, M. Ferrer, S.S. Joo, M. Martinez-Alonso, H. Matschinger, F. Mazzi, Z. Morgan, P. Morosini, C. Palacin, B. Romera, N. Taub, W.A. Vollebergh, Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr. Scand. 190(s420), 21\u201327 (2004). doi: 10.1111\/j.1600-0047.2004.00327.x","journal-title":"Acta Psychiatr. Scand."},{"key":"357_CR4","doi-asserted-by":"crossref","first-page":"b3999","DOI":"10.1136\/bmj.b3999","volume":"339","author":"M Moore","year":"2009","unstructured":"M. Moore, H.M. Yuen, N. Dunn, M.A. Mullee, J. Maskell, T. Kendrick, Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ 339, b3999 (2009). doi: 10.1136\/bmj.b3999","journal-title":"BMJ"},{"issue":"590","key":"357_CR5","doi-asserted-by":"crossref","first-page":"e565","DOI":"10.3399\/bjgp11X593848","volume":"61","author":"P Lockhart","year":"2011","unstructured":"P. Lockhart, B. Guthrie, Trends in primary care antidepressant prescribing 1995\u20132007: a longitudinal population database analysis. Br. J. Gen. Pract. 61(590), e565\u2013e572 (2011). doi: 10.3399\/bjgp11X593848","journal-title":"Br. J. Gen. Pract."},{"issue":"3","key":"357_CR6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bone.2012.05.018","volume":"51","author":"R Rizzoli","year":"2012","unstructured":"R. Rizzoli, C. Cooper, J.Y. Reginster, B. Abrahamsen, J.D. Adachi, M.L. Brandi, O. Bruyere, J. Compston, P. Ducy, S. Ferrari, N.C. Harvey, J.A. Kanis, G. Karsenty, A. Laslop, V. Rabenda, P. Vestergaard, Antidepressant medications and osteoporosis. Bone 51(3), 606\u2013613 (2012). doi: 10.1016\/j.bone.2012.05.018","journal-title":"Bone"},{"issue":"7192","key":"357_CR7","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/bmj.318.7192.1188","volume":"318","author":"O Spigset","year":"1999","unstructured":"O. Spigset, B. Martensson, Fortnightly review: drug treatment of depression. BMJ 318(7192), 1188\u20131191 (1999)","journal-title":"BMJ"},{"issue":"1","key":"357_CR8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bone.2009.07.083","volume":"46","author":"EM Haney","year":"2010","unstructured":"E.M. Haney, S.J. Warden, M.M. Bliziotes, Effects of selective serotonin reuptake inhibitors on bone health in adults: time for recommendations about screening, prevention and management? Bone 46(1), 13\u201317 (2010). doi: 10.1016\/j.bone.2009.07.083","journal-title":"Bone"},{"issue":"1","key":"357_CR9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1083\/jcb.201006123","volume":"191","author":"P Ducy","year":"2010","unstructured":"P. Ducy, G. Karsenty, The two faces of serotonin in bone biology. J. Cell Biol. 191(1), 7\u201313 (2010). doi: 10.1083\/jcb.201006123","journal-title":"J. Cell Biol."},{"issue":"2","key":"357_CR10","first-page":"133","volume":"8","author":"EM Haney","year":"2008","unstructured":"E.M. Haney, S.J. Warden, Skeletal effects of serotonin (5-hydroxytryptamine) transporter inhibition: evidence from clinical studies. J. Musculoskelet. Neuronal Interact. 8(2), 133\u2013145 (2008)","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"12","key":"357_CR11","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/archinte.167.12.1240","volume":"167","author":"SJ Diem","year":"2007","unstructured":"S.J. Diem, T.L. Blackwell, K.L. Stone, K. Yaffe, E.M. Haney, M.M. Bliziotes, K.E. Ensrud, Use of antidepressants and rates of hip bone loss in older women: the study of osteoporotic fractures. Arch. Intern. Med. 167(12), 1240\u20131245 (2007). doi: 10.1001\/archinte.167.12.1240","journal-title":"Arch. Intern. Med."},{"issue":"2","key":"357_CR12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/YIC.0b013e3282f2b3bb","volume":"23","author":"LJ Williams","year":"2008","unstructured":"L.J. Williams, M.J. Henry, M. Berk, S. Dodd, F.N. Jacka, M.A. Kotowicz, G.C. Nicholson, J.A. Pasco, Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. Int. Clin. Psychopharmacol. 23(2), 84\u201387 (2008). doi: 10.1097\/YIC.0b013e3282f2b3bb","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"12","key":"357_CR13","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/archinte.167.12.1246","volume":"167","author":"EM Haney","year":"2007","unstructured":"E.M. Haney, B.K. Chan, S.J. Diem, K.E. Ensrud, J.A. Cauley, E. Barrett-Connor, E. Orwoll, M.M. Bliziotes, Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch. Intern. Med. 167(12), 1246\u20131251 (2007). doi: 10.1001\/archinte.167.12.1246","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"357_CR14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1345\/aph.1L264","volume":"43","author":"R Ginzburg","year":"2009","unstructured":"R. Ginzburg, E. Rosero, Risk of fractures with selective serotonin-reuptake inhibitors or tricyclic antidepressants. Ann. Pharmacother. 43(1), 98\u2013103 (2009). doi: 10.1345\/aph.1L264","journal-title":"Ann. Pharmacother."},{"issue":"10","key":"357_CR15","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.euroneuro.2009.05.001","volume":"19","author":"S Schwan","year":"2009","unstructured":"S. Schwan, P. Hallberg, SSRIs, bone mineral density, and risk of fractures\u2014a review. Eur. Neuropsychopharmacol. 19(10), 683\u2013692 (2009). doi: 10.1016\/j.euroneuro.2009.05.001","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"4","key":"357_CR16","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.bone.2012.07.030","volume":"51","author":"V Rabenda","year":"2012","unstructured":"V. Rabenda, O. Bruyere, J.Y. Reginster, Risk of nonvertebral fractures among elderly postmenopausal women using antidepressants. Bone 51(4), 674\u2013679 (2012). doi: 10.1016\/j.bone.2012.07.030","journal-title":"Bone"},{"issue":"4","key":"357_CR17","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/ageing\/aft009","volume":"42","author":"MS Bakken","year":"2013","unstructured":"M.S. Bakken, A. Engeland, L.B. Engesaeter, A.H. Ranhoff, S. Hunskaar, S. Ruths, Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian Prescription Database and the Norwegian Hip Fracture Registry. Age Ageing 42(4), 514\u2013520 (2013). doi: 10.1093\/ageing\/aft009","journal-title":"Age Ageing"},{"issue":"3","key":"357_CR18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00198-013-2612-2","volume":"25","author":"D Prieto-Alhambra","year":"2014","unstructured":"D. Prieto-Alhambra, H. Petri, J.S. Goldenberg, T.P. Khong, O.H. Klungel, N.J. Robinson, F. de Vries, Excess risk of hip fractures attributable to the use of antidepressants in five European countries and the USA. Osteoporos. Int. 25(3), 847\u2013855 (2014). doi: 10.1007\/s00198-013-2612-2","journal-title":"Osteoporos. Int."},{"issue":"5","key":"357_CR19","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00198-014-2649-x","volume":"25","author":"C Moura","year":"2014","unstructured":"C. Moura, S. Bernatsky, M. Abrahamowicz, A. Papaioannou, L. Bessette, J. Adachi, D. Goltzman, J. Prior, N. Kreiger, T. Towheed, W.D. Leslie, S. Kaiser, G. Ioannidis, L. Pickard, L.A. Fraser, E. Rahme, Antidepressant use and 10-year incident fracture risk: the population-based Canadian Multicentre Osteoporosis Study (CaMoS). Osteoporos. Int. 25(5), 1473\u20131481 (2014). doi: 10.1007\/s00198-014-2649-x","journal-title":"Osteoporos. Int."},{"issue":"6","key":"357_CR20","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/clpt.2011.54","volume":"89","author":"JJ Gagne","year":"2011","unstructured":"J.J. Gagne, A.R. Patrick, H. Mogun, D.H. Solomon, Antidepressants and fracture risk in older adults: a comparative safety analysis. Clin. Pharmacol. Ther. 89(6), 880\u2013887 (2011). doi: 10.1038\/clpt.2011.54","journal-title":"Clin. Pharmacol. Ther."},{"issue":"1","key":"357_CR21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12020-011-9570-2","volume":"41","author":"G Mazziotti","year":"2012","unstructured":"G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41(1), 58\u201369 (2012). doi: 10.1007\/s12020-011-9570-2","journal-title":"Endocrine"},{"issue":"1","key":"357_CR22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12020-012-9691-2","volume":"42","author":"JF Griffith","year":"2012","unstructured":"J.F. Griffith, H.K. Genant, New advances in imaging osteoporosis and its complications. Endocrine 42(1), 39\u201351 (2012). doi: 10.1007\/s12020-012-9691-2","journal-title":"Endocrine"},{"issue":"4","key":"357_CR23","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/jbmr.1813","volume":"28","author":"Q Wu","year":"2013","unstructured":"Q. Wu, W. Qu, M.D. Crowell, J.G. Hentz, K.A. Frey, Tricyclic antidepressant use and risk of fractures: a meta-analysis of cohort and case-control studies. J. Bone Miner. Res. 28(4), 753\u2013763 (2013). doi: 10.1002\/jbmr.1813","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"357_CR24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00198-012-2015-9","volume":"24","author":"V Rabenda","year":"2013","unstructured":"V. Rabenda, D. Nicolet, C. Beaudart, O. Bruyere, J.Y. Reginster, Relationship between use of antidepressants and risk of fractures: a meta-analysis. Osteoporos. Int. 24(1), 121\u2013137 (2013). doi: 10.1007\/s00198-012-2015-9","journal-title":"Osteoporos. Int."},{"issue":"5","key":"357_CR25","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jbmr.1554","volume":"27","author":"CS Eom","year":"2012","unstructured":"C.S. Eom, H.K. Lee, S. Ye, S.M. Park, K.H. Cho, Use of selective serotonin reuptake inhibitors and risk of fracture: a systematic review and meta-analysis. J. Bone Miner. Res 27(5), 1186\u20131195 (2012). doi: 10.1002\/jbmr.1554","journal-title":"J. Bone Miner. Res"},{"issue":"7\u20138","key":"357_CR26","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1345\/aph.1Q589","volume":"46","author":"LH Oderda","year":"2012","unstructured":"L.H. Oderda, J.R. Young, C.V. Asche, G.A. Pepper, Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs. Ann. Pharmacother. 46(7\u20138), 917\u2013928 (2012). doi: 10.1345\/aph.1Q589","journal-title":"Ann. Pharmacother."},{"issue":"2","key":"357_CR27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0378-5122(99)00057-2","volume":"33","author":"JY Reginster","year":"1999","unstructured":"J.Y. Reginster, R. Deroisy, I. Paul, M. Hansenne, M. Ansseau, Depressive vulnerability is not an independent risk factor for osteoporosis in postmenopausal women. Maturitas 33(2), 133\u2013137 (1999)","journal-title":"Maturitas"},{"issue":"1","key":"357_CR28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1742-5573-1-3","volume":"1","author":"CV Phillips","year":"2004","unstructured":"C.V. Phillips, K.J. Goodman, The missed lessons of Sir Austin Bradford Hill. Epidemiol. Perspect. Innov. 1(1), 3 (2004). doi: 10.1186\/1742-5573-1-3","journal-title":"Epidemiol. Perspect. Innov."},{"issue":"10","key":"357_CR29","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1007\/s00198-009-0849-6","volume":"20","author":"MW Brand van den","year":"2009","unstructured":"M.W. van den Brand, S. Pouwels, M.M. Samson, T.P. van Staa, B. Thio, C. Cooper, H.G. Leufkens, A.C. Egberts, H.J. Verhaar, F. de Vries, Use of anti-depressants and the risk of fracture of the hip or femur. Osteopor. Int. 20(10), 1705\u20131713 (2009). doi: 10.1007\/s00198-009-0849-6","journal-title":"Osteopor. Int."},{"issue":"2","key":"357_CR30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00198-012-2043-5","volume":"24","author":"P Vestergaard","year":"2013","unstructured":"P. Vestergaard, D. Prieto-Alhambra, M.K. Javaid, C. Cooper, Fractures in users of antidepressants and anxiolytics and sedatives: effects of age and dose. Osteoporos. Int. 24(2), 671\u2013680 (2013). doi: 10.1007\/s00198-012-2043-5","journal-title":"Osteoporos. Int."},{"issue":"1","key":"357_CR31","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/0778-7367-71-2","volume":"71","author":"JM Robine","year":"2013","unstructured":"J.M. Robine, E. Cambois, W. Nusselder, B. Jeune, H.V. Oyen, C. Jagger, The joint action on healthy life years (JA: EHLEIS). Arch. Public Health 71(1), 2 (2013). doi: 10.1186\/0778-7367-71-2","journal-title":"Arch. Public Health"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0357-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-014-0357-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-014-0357-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T14:28:56Z","timestamp":1565706536000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-014-0357-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,5]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["357"],"URL":"https:\/\/doi.org\/10.1007\/s12020-014-0357-0","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,5]]}}}